OTC Market

The OTC market encompasses an enormous range of instruments — from the largest corporate bonds and government securities to the smallest speculative penny stocks — and understanding its structure, its regulatory framework, and its distinction from exchange markets is directly tested on the SIE, Series 7, and Series 63 examinations.

The Structural Distinction — OTC Versus Exchange Markets

The fundamental distinction between the OTC market and exchange markets is the mechanism through which transactions occur and the degree of centralisation in price discovery.

An exchange market is centralised — all orders in a given security flow to a single venue or a network of linked venues governed by Regulation NMS, are matched through a defined order priority system, and produce a single national best bid and offer visible to all market participants. 

The NYSE's auction structure and the NASDAQ's competing market maker model are both exchange structures, even though they operate differently from each other. Every transaction in an exchange-listed security contributes to the consolidated price discovery system.

The OTC market is decentralised — there is no single trading venue or centralised order book. Instead, broker-dealers post quotations in interdealer quotation systems indicating the prices at which they are willing to buy and sell specific OTC securities, and transactions occur through bilateral negotiation between the dealer and the counterparty. 

No single venue sees all OTC transactions. Price discovery is fragmented across multiple dealers, and investors must check multiple quotes to find the best available price.

This decentralised structure gives the OTC market its defining characteristics — greater flexibility, less regulatory uniformity, and a wider spectrum of securities and participants than exchange markets, alongside lower transparency and higher counterparty risk in some segments.

The Two Primary OTC Equity Quotation Systems

OTC equity securities are quoted through interdealer quotation systems that display market maker bids and asks. As confirmed by the SEC's Division of Market Regulation and by investor.gov, there are currently only two primary interdealer quotation systems for OTC equity securities — Global OTC ATS, operated by NYSE Group, and OTC Link ATS, operated by OTC Markets Group.

OTC Link ATS — operated by OTC Markets Group, Inc., formerly known as Pink OTC Markets Inc. — is the dominant contemporary platform for OTC equity quotation. OTC Link is an electronic interdealer quotation system that displays quotes, last-sale prices, and volume information in OTC equity securities, exchange-listed securities, foreign equity securities, and certain corporate debt securities. 

All subscribers to OTC Link are FINRA-member broker-dealers. Subscribers may quote any OTC equity security eligible under Exchange Act Rule 15c2-11 or applicable exemptions. OTC Link does not require companies whose securities are quoted on its systems to provide specified levels of disclosure — the disclosure requirement is addressed at the broker-dealer market maker level through Rule 15c2-11 rather than through OTC Link's own listing standards.

The OTC Bulletin Board — the OTCBB — was a FINRA-operated electronic interdealer quotation system that displayed quotes, last-sale prices, and volume information for OTC equity securities requiring current SEC reporting. FINRA formally closed the OTCBB on November 8, 2014, after OTC Markets Group had already become the primary gateway into the OTC securities market, rendering the OTCBB largely obsolete. Its closure formalised OTC Markets Group as the dominant OTC equity platform.

OTC Markets Group — The Three-Tier Structure

OTC Markets Group — a publicly traded company itself, trading on its own OTCQX market under the ticker OTCM — organises the securities quoted on its platforms into three tiers based on the quality and timeliness of company disclosure. This tier structure, introduced progressively beginning with the OTCQX launch in 2006, provides investors with a graduated framework for assessing the information available about OTC companies and the degree of regulatory oversight applicable to each tier.

The OTCQX Best Market is the highest tier, reserved for established domestic and international companies that meet substantial financial standards, maintain current reporting, and comply with corporate governance requirements. OTCQX companies may not be penny stocks, shell companies, or companies in bankruptcy proceedings. Many large foreign companies that meet exchange listing standards but choose not to list on a national exchange — opting instead for ADR or direct share quotation — appear on the OTCQX. OTCQX provides investor-facing transparency comparable to exchange-listed reporting issuers because its companies must file current public reports.

The OTCQB Venture Market is the middle tier, designed for early-stage domestic and international companies that maintain current public reporting and complete annual management verification and attestation requirements. Companies on the OTCQB must not be in bankruptcy and must maintain a minimum bid price of one cent per share. The OTCQB provides more accessible financial standards than the OTCQX while still requiring current information for market makers quoting the security.

The Pink Open Market — historically called the Pink Sheets before OTC Markets Group rebranded its platforms — is the lowest tier and the most permissive, providing broker-dealers with a regulated platform for transparent trading with minimal company disclosure requirements. Pink Market companies include foreign companies limiting their US disclosure, penny stocks, shell companies, and a broad range of smaller or less established issuers. The Pink Market operates under minimal financial disclosure requirements, meaning investors may have very limited public information about companies whose securities trade there.

SEC Rule 15c2-11 — The Broker-Dealer Gatekeeping Obligation

The primary regulatory mechanism protecting investors in OTC equity markets is SEC Rule 15c2-11 under the Securities Exchange Act of 1934, which restricts broker-dealers from publishing quotations for OTC equity securities unless they have reviewed current and publicly available information about the issuer. As confirmed by the SEC's investor.gov OTC securities resource, Rule 15c2-11 amendments restrict the ability of broker-dealers and market makers from publishing quotations for companies of OTC stocks that have not provided current and publicly available financial information.

The SEC substantially amended Rule 15c2-11 in September 2020, effective September 2021, to significantly strengthen the information review requirement. Under the amended rule, broker-dealers must review specified information about the issuer — including financial statements, the nature of the issuer's business, and information about officers and directors — before initiating or resuming quotation of an OTC security. The rule also created a new provision allowing broker-dealers to rely on a publicly available determination by a qualified interdealer quotation system that an issuer's information is current and publicly available, reducing the compliance burden for individual firms while maintaining the substantive information gatekeeping function.

The 2020 amendments were primarily designed to reduce quotations for so-called dark companies — issuers with no current public information — which had historically been vehicles for pump and dump manipulation schemes precisely because the absence of public information made artificial price promotion more effective and harder for investors to evaluate independently.

What Trades in the OTC Market

The OTC market is far larger than the exchange market in terms of total dollar value of securities outstanding, because the major fixed income markets — government securities, corporate bonds, municipal bonds, and agency securities — trade almost exclusively in the OTC market rather than on exchanges.

United States Treasury securities are exclusively OTC instruments. The Treasury market is the most liquid securities market in the world, with average daily trading volume exceeding five hundred billion dollars, but it operates entirely through a network of twenty-three primary dealers and the Federal Reserve Bank of New York rather than through any exchange. Corporate bonds are predominantly OTC instruments — the vast majority of corporate bond trading occurs through broker-dealer networks rather than on exchange bond platforms, with post-trade transparency provided by FINRA's TRACE system under FINRA Rule 6730 rather than through real-time exchange quotation. Municipal bonds are overwhelmingly OTC, quoted and traded between dealers with post-trade reporting through MSRB's EMMA system under MSRB Rule G-14.

OTC equity securities are a smaller component of the overall equity market by market capitalisation than exchange-listed securities, but they are numerous — OTC Markets Group lists over eleven thousand domestic and global securities on its three platforms. These include foreign securities that access the US market through ADRs, small and micro-cap domestic companies that do not meet exchange listing standards, shell companies, and speculative penny stocks.

Derivatives — including many interest rate swaps, credit default swaps, currency forwards, and exotic options — are predominantly OTC rather than exchange-traded. The Dodd-Frank Act of 2010 introduced mandatory clearing and reporting requirements for standardised OTC derivatives, requiring many previously bilateral OTC swap transactions to be cleared through central counterparties and reported to swap data repositories, substantially increasing the regulatory oversight of OTC derivatives without converting them to exchange instruments.

Regulatory Framework — SEC and FINRA Oversight

As confirmed by both FINRA's and the SEC's documentation on the OTC market, OTC equity trading is subject to regulation by the SEC and FINRA, particularly for broker-dealer conduct and trade reporting. The decentralised nature of the OTC market does not mean it operates without regulation — it means the regulatory framework addresses broker-dealer conduct and information disclosure rather than the market venue itself.

FINRA regulates all broker-dealers operating in the OTC equity market — whether as market makers posting two-sided quotations or as dealers executing customer transactions. FINRA Rule 6460 requires OTC market makers to display customer limit orders in their quotations when those orders improve upon the market maker's displayed prices. FINRA Rule 5310 requires best execution — OTC trades must be executed at the most favourable terms reasonably available, just as exchange trades must be. FINRA's TRACE system requires post-trade reporting of OTC fixed income transactions, providing the transparency for the corporate and agency bond OTC markets that exchange listing provides for equity markets.

SEC Rule 15c2-11 addresses the information gatekeeping function for OTC equity quotations. SEC Regulation ATS — codified at 17 CFR Part 242 — governs OTC Link and other alternative trading systems operating in the OTC equity market, requiring them to register with the SEC, file Form ATS, and comply with fair access requirements when their trading volume reaches specified thresholds. These regulatory frameworks collectively impose meaningful oversight on OTC markets while preserving the flexibility and decentralisation that distinguish the OTC structure from exchange markets.

Risks of OTC Trading

OTC markets carry several risks that are higher than those typical of exchange-listed securities, and securities professionals must understand these risks for suitability analysis purposes under FINRA Rule 2111 and Regulation Best Interest.

Transparency is lower in OTC markets than in exchange markets, particularly in the lower tiers of OTC equity quotation. Fixed income OTC markets have improved substantially with TRACE and EMMA post-trade reporting, but the pre-trade transparency — the visibility of bids and offers before transactions execute — is still far less developed than in exchange equity markets.

Liquidity risk is substantially higher for OTC equity securities — particularly in the Pink Market — than for exchange-listed securities. Bid-ask spreads can be wide, daily volume can be minimal, and the investor seeking to sell a large position may move the market against themselves significantly or may be unable to find a buyer at any reasonable price.

Fraud and manipulation risk is elevated in lower-tier OTC equity markets. The absence of disclosure requirements in the Pink Market historically made it a preferred venue for pump and dump schemes targeting retail investors who may not appreciate the limited information available. The SEC issues stern investor warnings about OTC penny stock fraud and manipulation schemes, recommending that investors research any OTC company thoroughly before investing.

Examination Relevance and Key Takeaways

The OTC market is tested on the SIE, Series 7, and Series 63 examinations in the context of market structure, the distinction between exchange and OTC markets, the quotation systems, and the regulatory framework.

The key points to retain are these.

The OTC market is a decentralised dealer market in which securities trade through bilateral negotiated transactions between broker-dealers rather than through a centralised exchange order book — there is no single trading floor or electronic matching engine. 

OTC securities are securities not listed on a national securities exchange. The two primary interdealer quotation systems for OTC equities are Global OTC ATS operated by NYSE Group and OTC Link ATS operated by OTC Markets Group — with OTC Link the dominant platform following FINRA's closure of the OTCBB on November 8, 2014. 

OTC Markets Group organises quoted securities into three tiers — OTCQX Best Market requiring substantial financial standards and current disclosure, OTCQB Venture Market for early-stage companies with current reporting, and the Pink Open Market with minimal disclosure requirements — providing investors with a graduated transparency framework. 

SEC Rule 15c2-11 requires broker-dealers to review current public information about issuers before publishing quotations, with 2020 amendments strengthening the information gatekeeping requirement and restricting quotations for dark companies without current public disclosure. 

Major fixed income markets including Treasuries, corporate bonds, and municipal bonds trade exclusively in the OTC market — making OTC the dominant structure by total dollar value despite the higher profile of exchange-listed equities. 

FINRA regulates OTC broker-dealer conduct including best execution under Rule 5310, limit order display under Rule 6460, and post-trade reporting of fixed income transactions through TRACE under Rule 6730. OTC markets carry elevated transparency, liquidity, and fraud risks compared to exchange markets, particularly in lower-tier OTC equity securities.